Navigation Links
Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results
Date:11/3/2011

productlicense right

171,727171,732515,180515,184Other

31,68027,86980,73583,283Total costs and expenses

9,955,9189,747,01329,972,72828,797,232Operating income

3,098,3602,443,8578,138,2184,264,225Interest income

52,45948,675147,628159,688Interest expense

(33,390)(547,795)(329,037)(1,299,703)Income before income taxes

3,117,4291,944,7377,956,8093,124,210Income tax expense

(1,278,472)(943,141)(3,238,421)(1,529,339)Net income

1,838,9571,001,5964,718,3881,594,871Net loss at subsidiary attributable tononcontrolling interests

8,4556,64827,80324,255Net income attributable tocommon shareholders

$
,847,412$
,008,244$
4,746,191$
,619,126Earnings per share attributable to common shareholders- basic

$
.09$
.05$
.23$
.08- diluted

$
.09$
.05$
.23$
.08Weighted-average shares outstanding- basic

20,327,53720,327,86720,414,59320,335,911- diluted

20,534,64720,803,18220,657,56721,135,762CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
(Unaudited)Nine Months Ended September 30,20112010Cash flows from operating activities:Net income

$
4,718,388$
,594,871Adjustments to reconcile net income to net cash flows fromoperating activities:Depreciation and amortization expense

801,483723,687Non-employee equity compensation

119,31362,547Stock-based compensation - employee stock options

467,850503,446Excess tax benefit derived from exercise of stock options

(2,657,259)(1,256,913)Non-cash interest expense

131,469328,475Net changes in assets and liabilities affectingoperating activities:Accounts receivable

640,0831,384,903Inventory

809,243(2,823,355)Other current assets and other assets

(1,240,700)1,461,538Accounts payable and other accrued liabilities

3,911,450(840,429)Other long-term obligations

(9,262)(105,668)
'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Cumberland Pharmaceuticals Taps Industry Veteran for Key Executive Position
2. Neurotech Announces the Opening of Its GMP Manufacturing Facility in Cumberland, Rhode Island
3. Cumberland Pharmaceuticals Appoints Lee Product Director
4. Cumberland Emerging Technologies and UT Research Foundation Sign License Agreement for New Technology
5. Cumberland Pharmaceuticals Provides Hospital In-Service Webcast for Acetadote(R)
6. Cumberland Pharmaceuticals Announces FDA Approval of Caldolor(TM)
7. Cumberland Pharmaceuticals Announces Pricing of Its Initial Public Offering of Common Stock
8. Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
10. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
11. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... Healthcare,Acquisition Corp. (Amex: MBH ), a publicly ... and Critical Homecare,Solutions Holdings, Inc., a privately-owned, leading ... services, are,scheduled to present on Tuesday, March 18, ... Conference in Miami, Florida. On February,6, 2008, MBH ...
... planned on the genetics of;, - Asian populations with regard ... ... to athletic/exercise performance ... regard to skin appearance (dermagenomics), WALTHAM, Mass., Feb. 28 ...
... Japanese medical centres in presenting data on ... clinical utility of EAA(TM) diagnostic-, ... SDI) today announced that it will present new findings ... the only FDA,cleared diagnostic for the measurement of endotoxin, ...
Cached Biology Technology:MBF Healthcare Acquisition Corp. and Critical Homecare Solutions Holdings, Inc. to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference 2MBF Healthcare Acquisition Corp. and Critical Homecare Solutions Holdings, Inc. to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference 3Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor 2Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor 3Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor 4Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor 5Spectral announces data on the clinical utility of EAA(TM) to be presented at 12th Annual Critical Care for Endotoxemia Conference in Japan 2
(Date:4/14/2014)... ARBORA 32-year study of subarctic forest moths in Finnish ... of climate change on animals and plants because much ... study analyzed populations of 80 moth species and found ... increasing throughout the study period, from 1978 to 2009. ... site rose 3.5 degrees Fahrenheit, and winter precipitation increased ...
(Date:4/14/2014)... climate over the past three decades have caused small ... national animal. UCLA biologists have found that not only ... has also become shorter and higher pitched. ... integrative biology and physiology and of ecology and evolutionary ... study examined 170 male coqui frogs ( Eleutherodactylus coqui ...
(Date:4/14/2014)... ) David Kisailus, the Winston Chung Endowed ... California, Riverside,s Bourns College of Engineering, has been ... young scientists selected by the advisory board of ... of Sciences and organizers of the Kavli/National Academy ... Kavli Foundation, which is based in Oxnard, supports ...
Breaking Biology News(10 mins):Moth study suggests hidden climate change impacts 2Moth study suggests hidden climate change impacts 3Climate change a likely culprit in coqui frog's altered calls, say UCLA biologists 2Professor receives young scientist honor 2
... of cardiac therapeutics have long looked to the future when ... one,s own heart cells. A study published in the February ... American Heart Association, shows that heart stem cells from children ... heart in the laboratory. Sunjay ...
... Visionaries in the field of cardiac therapeutics have long looked ... or repaired by using one,s own heart cells. A study ... scientific journal of the American Heart Association, shows that heart ... to rebuild the damaged heart in an animal model. ...
... A Kansas State University scientist is digging deep to ... groundwater and aquifers. Tungsten is a naturally occurring ... is primarily used for incandescent lightbulb filaments and X-ray ... the environment, tungsten is replacing lead in fishing weights ...
Cached Biology News:Stem cells show promise in repairing a child's heart 2Using a child's own stem cells to repair their heart looks promising 2National study explores the reaction and transport of tungsten in drinking water 2
Mol wt: average mol wt16,951.27 Da by calculation...
A set of five peptides which can be used to calibrate a Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) or Electrospray Ionization (ESI) mass spectrometer....
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. ID clarifier: filling ...
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. ID clarifier: ...
Biology Products: